OFPP Seeks to Debunk Myths about Debriefings
Client Alert | less than 1 min read | 01.27.17
On January 5, 2017, the Office of Federal Procurement Policy (OFPP) issued its third "Myth-busting" memorandum, specifically addressing misconceptions about debriefings. By issuing this memorandum, OFPP seeks to encourage the use of debriefings as a tool that could contribute to a potentially more competitive supplier base and also allow agencies to evaluate and improve their own processes. In addition to attempting to debunk some common myths about debriefings, the memorandum sets forth best practices, including the adoption or establishment of a debriefing guide.
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
